← Eichor
Study identifier: NCT03991897 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Nutritional Ketosis: a Novel Metabolic Strategy to Treat Lymphedema Patients?

Condition: Lymphedema · Ketogenic Dieting · Ketone Ester Supplement  ·  Sponsor: Universitaire Ziekenhuizen KU Leuven

PhaseNA
Planned participants81
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Lymphedema is a debilitating disorder that severely impairs the quality of life of the patients and requires life-long attention. Treatment for lymphatic dysfunction remains largely symptomatic, without real cure. According to the International Society of Lymphology, lymphedema has to be treated with Decongestive Lymphatic Therapy. Research in the lab of Angiogenesis and Vascular Metabolism (PCA lab) reported in mice that metabolism of endothelial cells controls vessel sprouting. Experiments showed that a ketogenic diet (KD) reduced the edema of the mice tail and enhanced the lymphatic transport. Based on these proof-of-concept data, the investigators plan to test this innovative concept to ameliorate lymph vessel dysfunction in lymphedema patients. Randomisation will be performed between a ketogenic diet and an isocaloric diet with and without ketone ester supplementation.

This description comes directly from the study's public registry record.

Talk to the study team

Sarah Thomis, MD  ·  003216346948  ·  sarah.thomis@uzleuven.be

Christoph Matthys, PhD  ·  003216342655  ·  christophe.matthys@uzleuven.be

Always discuss trial participation with your own doctor first.

Locations (1)

UZ LeuvenLeuven, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03991897